David Martin Email & Phone Number
Chief Executive Officer, Co-Founder, Director
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
David Martin Location
- Shawnee, OK, US
David Martin Work
- 2025 -now Chief Executive Officer, Co-Founder, Director @ Host Therapeutics, Inc.
- 2024 -now Chief Development Officer @
- 2023 -now Associate Editor - Virology @ Frontiers in Microbiology
- 2021 -now President and CEO @
- 2011 -now Founder and Managing Partner @ Martin Pharma Consulting, LLC
- 2020 -now Director, Board Of Directors @
- 2018 -now Member, Investment Advisory Committee @
- 2017 -now Member Board of Directors @
- 2011 -now Founder and Director, Board of Directors @ DFH Pharma, Inc.
- 2019 -2020 Founder and Chief Executive Officer @ Kirrhos Pharmaceuticals
- 2009 -2011 Senior Vice President, Drug Development and Regulatory Affairs @ Tobira Therapeutics
- 2001 -2008 Senior Vice President, Drug Development and Regulatory Affairs @
- 1999 -2001 Director, Clinical Pharmacology @
- 1997 -1999 Assistant Director, Virology @ PharmaResearch Corporation
- 1994 -1997 Assistant Director, Clinical Pharmacology @ SmithKline Beecham Corporation
- 1992 -1994 Drug Development Fellowship @
- 1991 -1992 Clinical Pharmacy Resident @
David Martin Education
- Saint Joseph's University - Erivan K. Haub School of Business
MBA (Pharmaceutical Marketing)
2000-2003 - University of Southern California, School of Pharmacy
PharmD (Pharmacy)
1987-1991 - East Central University
(Pre-Pharmacy Studies)
1984-1987
David Martin Skills
- Drug Development
- Clinical Development
- HIV/AIDS
- Clinical Pharmacology
- Clinical Trials
- Clinical Trial Management
- Pharmacokinetics
- Drug Discovery
- Pre-clinical development
- Research Project Management
- Regulatory Affairs
- Fundraising
- Board Level
- Advisory Boards
- Consultancy
- Start-ups
- Strategic Planning
- Due Diligence
- Project Management
- FDA
- CRO
- CTMS
- Pharmaceutical Industry
- Biotechnology
- Clinical Research
- Regulatory Submissions
- Infectious Diseases
- IND
- Biopharmaceuticals
- Pharmaceutics
- Lifesciences
- Technology Transfer
- Life Sciences
- Consulting
- Financial Advisory
- Patent Applications
- Thailand
- Channel
- Pharmacotherapy
- Stock Market
- Analog
- Davidson
- ADME
- Hospital Sales
- Dec Alpha
- NDA
- ADHD
- Dispositions
- Literature
- Mass Spectrometry
- Neuropsychopharmacology
- Treatment
- Nih
- Microbiology
- Replication
- Acid
- Design
- Jamaica
- Schizophrenia
- PMC
- Mexico
- Venture Financing
- Correlation
- Iia
- Cros
- Elimination
- Clinical Strategy
- Reaction
- Press Releases
- Dependent
- System
- Corporate Communications
- Hospice
- MAP
- Drug Testing
- Rabbit
- Medicine
- ACAD
- Puerto Rico
- African
- Contract Negotiation
- Drug Interactions
- Diabetes
- Chicago
- Board of Directors
- Pro*C
- Pathogenesis
- Los Angeles
- Hospitals
- Urology
- C
- Renal
- Business Development
- Communication
- Phase 2
- Modeling
- Negotiation
- Efficacy
- Active
- Scientific
- Safety
- Austria
- Depression
- Toronto
- Array
- Scotland
- France
- Pharmacy
- Structural Biology
- Vienna
- Responsibility
- Usa
- Regulations
- International
- Facts
- Proof of Concept
- Letters of Credit
- Disclosure
- Business Insights
- Citations
- San Francisco
- Canada
- In Vitro
- Cardiac
- Antiviral
- Hawaii
- Ep
- Regulatory Development
- Risk
- Filing
- North American
- Writing
- RF
- Sound
- Oklahoma
- Chemistry
- Phase Ii
- England
- Finance
- Calcium
- End Stage Renal Disease
- Pharm
- Symposium
- Australia
- Sbir
- RNA
- Clinical Monitoring
- Cancer
- Canadian
- Biopharm
- Pain Management
- Simulations
- PC
- Rats
- Phase 1
- Patents
- Sensitivity
- Mouse
- PK/PD
- Fusion
- Atlanta
- Project Leadership
- ATV
- Press
- Institutes
- Conferences
- Ratios
- Research
- System Monitoring
- National Service
- Investigation
- Binding
- Suzuki
- Advertising Agency
- Power
- Metabolism
- Trials
- Selecting
- FIX Protocol
- Maa
- IV
- DNA
- Advertising
- Posters
- Opportunistic
- Bangkok
- Project Planning
- Distribution Center Operations
- Islands
- Absorption
- Bronze
- Presentations
- Wilton
- Spain
- Rome
- Therapists
- Targeted Advertising
- Comparison
- Germany
- Biology
- Publication Strategy
- Brazil
- Curriculum Design
- Gold
- San Diego
- Development Strategy
- Bps
- Resistance
- Stocks
- Network Communications
- Structural Engineering
- Hemodialysis
- Schneider
- Mechanism Of Action
- Italy
- Pharmacodynamics
- Arranging
- Formulation
- Congress
- Elder Care
- Esi Ms
- Mergers and Acquisitions
- Evaluation
- Acts
- Chemical
- Surgery
- Hv
- Sales Operations
- Pacific
- SAN
- Road
- Drug Resistance
- Scholarships
- Aggregate
- Identifies
- Journals
- Programming Languages
- HIV
- Integration
- Clinical Pharmacy
- Publications
- Collaborative
- Pennsylvania
- Chemotherapy
- Philadelphia
- Dosing
- Rfa
- Safety Monitoring
- Strategy
- Walker
- Smx
- Progression
- Plasma Physics
- Virus
- Gender
- American
- Analysis
- Laboratory
- Inactive
- Antibacterial
- R
- Implications
- Applications
- Data Analysis
- Characterization
- Licensure
- Workshops
- Values
- Author
- Obesity
- Pharmacology
- Project
- Contractual Agreements
- Abuse
- Liver
- Urea
- Mc
- ERD
- Montreal
- Biopharmaceutics
- Psychopharmacology
- Rio
- Condensation
- Trial Management
- Kinetics
- Reviews
- Academic
- Profiles
- Emerging Infectious Diseases
- Subjects
- Moderate
- Business Strategy
- Infection
- Delivery
- Diabetic
- CICS
- Vascular
- Sellers
- In Vivo
- Solid Tumor
- Hypertension
- Concentrations
- Cape
- Wood
- Derivatives
- Seattle
- Immunology
- SEC filings
- Structure
- Oversight
- Aol
- Induction
- Analogue
- Pharmaceutical Companies
- Offerings
- South Africa
- Assessment
- Disease
- GL
- DJ
- Management
- Ftc
- Public Relations
- Synthetic
- Monitors
- Boston
- Public Speaking
- Pipe
- Execution
- Cardiovascular
- Drug Metabolism
- Foundation
- Cell
- Virology
- Offering
- In Licensing
- Baltimore
- Asia
- Dogs
- Agreement
- Cystic Fibrosis
- Denver
- Training
- Vis
- Patient
- Silver
- Materials Management
- Informatics
- R&D
- Abstracts
- Combination
- Comparisons
- Shareholders
- Thompson
- Clinical Study Design
- Evidence
- Operational Activities
- Migraine
- Americans with Disabilities Act
- Editorial
- Xiv
- Licensing
- Miller
- Degrees
- Keystone
- Bioavailability
- Software Lifecycle
- Measurements
- Distribution
- Executive Management
- Urine
- Report Writing
- Expression
- Grants
- Government
- Prevention
- SCI Clearance
- Wang
- DoubleClick
- UDP
- Study Reports
- Annual Reports
- Phase
- Manuscript Development
- Agents
- Rtv
- Manufacturing
- Sydney
- Managed Care
- Stability
- Mandt
- Art Exhibitions
- Central Nervous System
- IFRS
- Meetings
- Summit
- Abstraction
- Humans
- Local Service
- Pre Clinical Development
- Clinical Trial Management System
- Start Ups
- Medical Writing
- Good Clinical Practice
- Cross Functional Team Leadership
David Martin Summary
- David Martin, based in Shawnee, OK, US, is currently a Chief Executive Officer, Co-Founder, Director at Host Therapeutics, Inc.. David Martin brings experience from previous roles at Cadenza Bio, Frontiers in Microbiology, TrippBio and Martin Pharma Consulting, LLC. David Martin holds a 2000 - 2003 MBA in Pharmaceutical Marketing @ Saint Joseph's University - Erivan K. Haub School of Business. With a robust skill set that includes Drug Development, Clinical Development, HIV/AIDS, Clinical Pharmacology, Clinical Trials and more. David Martin has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different David Martin?
Find contact details for 700 million professionals.
Others Named David Martin
David Martin
Founder and Editor in Chief and Creative Director
New York, NY, US
David Martin
CEO and EVP
Chicago, IL, US
David Martin
Chief Revenue Officer (CRO) - Digital
New York, NY, US
David Martin
CEO
London, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co